ALTIMMUNE, INC. (ALT) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 34.74M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | 326.28M USD | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 527.21M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | (m) | $34.74M | (m) | $326.28M | $527.21M | (m) |
| 2026-03-31 | (m) | (m) | (m) | $34.51M | (m) | (m) | $335.63M | (m) |
| 2025-12-31 | (m) | (m) | (m) | $34.29M | (m) | (m) | $279.93M | (m) |
| 2025-09-30 | (m) | (m) | (m) | $14.45M | (m) | (m) | $218.45M | (m) |
| 2025-06-30 | (m) | (m) | (m) | $14.33M | (m) | (m) | $190.35M | (m) |
| 2023-09-30 | (m) | (m) | (m) | $4.30M | (m) | (m) | $166.57M | (m) |
| 2023-06-30 | (m) | (m) | (m) | $4.17M | (m) | (m) | $183.32M | (m) |
| 2023-03-31 | (m) | (m) | (m) | $4.40M | (m) | (m) | $187.08M | (m) |
| 2022-12-31 | (m) | (m) | (m) | $4.58M | (m) | (m) | $206.93M | (m) |
| 2022-09-30 | (m) | (m) | (m) | $4.51M | (m) | (m) | $225.28M | (m) |
| 2022-06-30 | (m) | (m) | (m) | $1.53M | (m) | (m) | $209.91M | (m) |
| 2022-03-31 | (m) | (m) | (m) | $1.67M | (m) | (m) | $205.66M | (m) |
| 2021-12-31 | (m) | (m) | (m) | $1.45M | (m) | (m) | $218.86M | (m) |
| 2021-09-30 | (m) | (m) | (m) | $1.57M | (m) | (m) | $236.91M | (m) |
| 2021-06-30 | (m) | (m) | (m) | $1.62M | (m) | (m) | $257.26M | (m) |
| 2021-03-31 | (m) | (m) | (m) | $1.72M | (m) | (m) | $264.25M | (m) |
| 2020-12-31 | (m) | (m) | (m) | $1.83M | (m) | (m) | $245.12M | (m) |
| 2020-09-30 | (m) | (m) | (m) | $1.93M | (m) | (m) | $233.00M | (m) |
| 2020-06-30 | (m) | (m) | (m) | $1.72M | (m) | (m) | $102.54M | (m) |
| 2020-03-31 | (m) | (m) | (m) | $1.79M | (m) | (m) | $54.23M | (m) |
| 2019-12-31 | (m) | (m) | (m) | $1.86M | (m) | (m) | $54.06M | (m) |
| 2019-09-30 | (m) | (m) | (m) | $1.79M | (m) | (m) | $56.39M | (m) |
| 2019-06-30 | (m) | (m) | (m) | $2.21M | (m) | (m) | $61.98M | (m) |
| 2019-03-31 | (m) | (m) | (m) | $2.32M | (m) | (m) | $65.37M | (m) |
| 2018-12-31 | (m) | (m) | (m) | $1.85M | (m) | (m) | $54.75M | (m) |
| 2015-12-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | $19.86M | (m) |
| 2015-06-30 | (m) | (m) | $249.49K | (m) | (m) | (m) | $22.62M | (m) |
| 2015-03-31 | (m) | (m) | $498.20K | (m) | (m) | (m) | $25.47M | (m) |
| 2014-12-31 | (m) | (m) | $746.15K | (m) | (m) | (m) | $21.98M | (m) |
| 2014-09-30 | (m) | (m) | $993.32K | (m) | (m) | (m) | $23.35M | (m) |
| 2014-06-30 | (m) | (m) | $1000.00K | $239.74K | (m) | (m) | $15.22M | (m) |
| 2014-03-31 | (m) | (m) | $1000.00K | $485.39K | (m) | (m) | $14.37M | (m) |
| 2013-12-31 | (m) | (m) | $1000.00K | $730.28K | (m) | (m) | $17.14M | (m) |
| 2013-09-30 | (m) | (m) | $1000.00K | $974.41K | (m) | (m) | $20.62M | (m) |
| 2013-06-30 | (m) | (m) | $1000.00K | $1.22M | (m) | (m) | $24.59M | (m) |
| 2013-03-31 | (m) | (m) | $1000.00K | $1.46M | (m) | (m) | $21.97M | (m) |
| 2012-12-31 | (m) | (m) | $750.00K | $1.70M | (m) | (m) | $22.74M | (m) |
| 2012-09-30 | (m) | (m) | $681.82K | $1.76M | (m) | (m) | $23.41M | (m) |
| 2012-06-30 | (m) | (m) | $454.55K | $1.98M | (m) | (m) | $23.81M | (m) |
| 2012-03-31 | (m) | (m) | $195.41K | $2.23M | (m) | (m) | $24.75M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |